ArticleCureus2025
Risperidone-Induced Urinary Retention: A Case Report Highlighting Urological Complications in Long-Term Use of Antipsychotic Medication.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary retention is a urological emergency that can lead to serious complications if left untreated. Although rare, risperidone has been associated with urinary retention through anticholinergic effects and modulation of dopaminergic and serotonergic pathways, which can inhibit detrusor muscle contractility and increase urethral sphincter activity. This report presents the case of a 54-year-old male patient who experienced multiple episodes of urinary retention that resulted in gross hematuria, hydronephrosis, and hospital admissions; this was considered to be caused by risperidone, which he was taking for bipolar disorder. This case highlights the importance of considering medication side effects in patients with recurrent urological issues, particularly those with multiple comorbidities. By contributing to the limited literature on risperidone-induced urinary retention, this report aims to enhance clinical awareness and guide decision-making in similar presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.